(Q83999880)
English
Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage dur
scientific article published on 27 April 2011
Statements
Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial (English)
Elisabetta Ricottini
Annunziata Nusca
Giuseppe Colonna
Vincenzo Pasceri
Andrea D'Ambrosio
Antonio Montinaro